Target intelligence / Profile preview

Rho GTPase activating protein 27 pseudogene 2 (ARHGAP27P2)

Target
ARHGAP27P2
Molecular classification
Pseudogene
01

Overview

Rho GTPase activating protein 27 pseudogene 2 (ARHGAP27P2) is classified as a pseudogene, meaning it is a nonfunctional DNA segment that resembles the functional ARHGAP27 gene but does not encode an active protein product in humans[3][7][8][9][10]. Pseudogenes like ARHGAP27P2 arise through gene duplication or retrotransposition events and typically contain significant mutations or disruptions (such as frameshifts or premature stop codons) that prevent production of a functional protein[10]. As such, ARHGAP27P2 is not a therapeutic or biological target (such as a receptor or enzyme) and does not possess described molecular function, associated disease roles, or drug interactions. It serves primarily as a genomic relic with no known physiological or pathological function in humans[9][10].\n\nKey clarification:\nAlthough the closely related ARHGAP27 gene encodes an active member of the Rho GTPase activating protein family involved in cytoskeletal regulation and is implicated in several diseases, ARHGAP27P2 is a distinct, nonfunctional pseudogene and does not have the same functional or therapeutic relevance[1][3][5][9].

Beyond the preview

Go deeper on Rho GTPase activating protein 27 pseudogene 2 (ARHGAP27P2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Rho GTPase activating protein 27 pseudogene 2 (ARHGAP27P2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call